Concepedia

Injection-site reaction to etanercept: role of skin test in the diagnosis of such reaction and successful desensitization

Sevim Bavbek, Ömür Aydın, Şebnem Ataman, Kenneth V. Cahill, M. Castells

Allergy · 2011 · 28 citations · 6 references

DOIFull text

Open access

Concepts

Abstract

cystic fibrosis), warrant a randomised, double blind study of ABPA with a follow-up of at least 1 year.

References

6

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial

John C. Davis, Désirée van der Heijde, Jürgen Braun et al. · Arthritis & Rheumatism · 2003 · 763 citations

, , +8

ASAS/EULAR recommendations for the management of ankylosing spondylitis

Jane Zochling · Annals of the Rheumatic Diseases · 2005 · 704 citations · Full text

, , +14

First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis

Jürgen Braun, John C. Davis, M Dougados et al. · Annals of the Rheumatic Diseases · 2005 · 385 citations · Full text

, , +12

Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein.

Rephael Zeltser, Laura Valle, Carol Tanck et al. · PubMed · 2001 · 170 citations

, , +17

Eosinophilic Cellulitislike Reaction to Subcutaneous Etanercept Injection

Harry L. Winfield, Edward Lain, Thomas Horn et al. · Archives of Dermatology · 2006 · 80 citations

, , +17